9000M
2021-07-30

$Annovis Bio, Inc.(ANVS)$

Very hard to find a drug for a disease for which etiology is not/or very poorly understood. In 20 years only one new drug was FDA approved for Alzheimer, the recent one from Biogen (Aduhelm) and even this was not meet in without controversy regarding its efficacy. Unfortunately, Annovis Bio just one of so many failed attempts in treating Alzheimer.

免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法